当前位置:首页 - 行情中心 - 亚太药业(002370) - 财务分析

亚太药业

(002370)

  

流通市值:28.04亿  总市值:28.04亿
流通股本:7.46亿   总股本:7.46亿

亚太药业(002370)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.08亿元,每股收益-0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益99786.12万元,未分配利润-179506.77万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产144105.01万元,负债44318.89万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入64,550,537.91405,174,661.29306,835,789.08221,933,271.08
营业总成本70,881,335.56430,113,073.56327,680,456.45228,077,115.52
营业利润-8,004,545.728,155,478.29-3,202,585.735,167,696.58
利润总额-8,014,554.3234,485,494.79-3,302,654.225,060,338.09
净利润-7,803,212.7134,239,781.33-3,459,530.475,475,173.86
其他综合收益-598,381.19598,381.19598,381.19
综合收益总额-7,803,212.7134,838,162.52-2,861,149.286,073,555.05
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,004,629,123.68955,160,389.32904,554,664.43911,842,593.97
非流动资产合计436,421,017.37446,607,979.12453,469,202.84456,900,483.41
资产总计1,441,050,141.051,401,768,368.441,358,023,867.271,368,743,077.38
流动负债合计430,549,120.02416,436,455.6686,125,279.06735,558,055.99
非流动负债合计12,639,826.0213,150,909.2246,472,056.1646,200,085.66
负债合计443,188,946.04429,587,364.82732,597,335.22781,758,141.65
归属于母公司股东权益合计997,861,195.01972,181,003.62625,426,532.05586,984,935.73
股东权益合计997,861,195.01972,181,003.62625,426,532.05586,984,935.73
负债和股东权益合计1,441,050,141.051,401,768,368.441,358,023,867.271,368,743,077.38
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计55,181,607.33266,034,964.46206,978,740.21152,155,376.22
经营活动现金流出小计43,606,808.2241,681,856.14171,108,464.35119,757,018.32
经营活动产生的现金流量净额11,574,799.1324,353,108.3235,870,275.8632,398,357.9
投资活动现金流入小计32,253,645.4116,803,318.52,026,063.67822,168.18
投资活动现金流出小计417,4549,794,862.27,133,372.295,208,661.29
投资活动产生的现金流量净额31,836,191.417,008,456.3-5,107,308.62-4,386,493.11
筹资活动现金流入小计-30,000,000--
筹资活动现金流出小计246,500.0161,905,366.2261,901,761.861,901,761.8
筹资活动产生的现金流量净额-246,500.01-31,905,366.22-61,901,761.8-61,901,761.8
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额43,164,490.53-543,801.6-31,138,794.56-33,889,897.01
期末现金及现金等价物余额762,863,213.79719,698,723.26689,103,730.3686,352,627.85
TOP↑